Skip to content

#辉瑞

Today 0 items
Oct 9Fri
  1. biorxiv.org51

    Single-nucleus multi-omics reveals reversible molecular signatures in skeletal muscle of patients with heart failure with preserved ejection fraction

    Single-nucleus multiome profiling of 140 skeletal muscle biopsies from 95 individuals (25 healthy controls, 70 HFpEF patients) maps molecular signatures of skeletal muscle remodeling in HFpEF, including type 1 fiber and pericyte depletion and type 2x fiber enrichment. Paired biopsies from 45 HFpEF patients before and after a supervised diet and exercise intervention show the chromatin accessibility and transcriptional changes were partially reversible. HFpEF-linked chromatin was enriched for heart failure and cardiometabolic GWAS signals.

Aug 30Sun
  1. NEJM Evid63

    Durability of RSV Prefusion F Vaccine Protection across Two RSV Seasons.

    A single dose of the RSVpreF vaccine remained associated with fewer RSV-related RTD hospitalizations among adults 60 years or older in a second RSV season, with an incidence of 0.11 versus 0.25 events per 1000 person-years and vaccine effectiveness of 56.2% (95% CI, -12.4% to 84.8%), down from 83.3% in season one. Across both seasons of the 130,991-participant intention-to-treat analysis, vaccine effectiveness was 70.6% (95% CI, 39.1%-87.0%). The results extend RSVpreF protection beyond one season while indicating waning estimates.

    Why it matters: First randomized data on how well one RSVpreF dose protects older adults through a second RSV season.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org